A detailed history of Ranch Capital Advisors Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ranch Capital Advisors Inc. holds 12,402 shares of GILD stock, worth $1.17 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
12,402
Previous 11,505 7.8%
Holding current value
$1.17 Million
Previous $789,000 31.69%
% of portfolio
0.49%
Previous 0.41%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $59,731 - $75,339
897 Added 7.8%
12,402 $1.04 Million
Q2 2024

Aug 13, 2024

BUY
$63.15 - $72.88 $4,673 - $5,393
74 Added 0.65%
11,505 $789,000
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $15,389 - $18,767
215 Added 1.92%
11,431 $837,000
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $328,909 - $372,991
-4,489 Reduced 28.58%
11,216 $908,000
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $25,213 - $27,508
341 Added 2.22%
15,705 $1.18 Million
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $5,776 - $6,589
-76 Reduced 0.49%
15,364 $1.18 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $38,268 - $43,599
495 Added 3.31%
15,440 $1.28 Million
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $255,387 - $366,648
-4,098 Reduced 21.52%
14,945 $1.28 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $19,648 - $22,443
330 Added 1.76%
19,043 $1.18 Million
Q2 2022

Aug 10, 2022

BUY
$57.72 - $65.01 $123,289 - $138,861
2,136 Added 12.89%
18,713 $1.16 Million
Q1 2022

May 12, 2022

BUY
$57.92 - $72.58 $358,698 - $449,487
6,193 Added 59.64%
16,577 $986,000
Q4 2021

Feb 08, 2022

BUY
$64.88 - $73.64 $9,732 - $11,046
150 Added 1.47%
10,384 $754,000
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $672,229 - $725,260
9,931 Added 3277.56%
10,234 $715,000
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $4,252 - $4,646
-67 Reduced 18.11%
303 $20,000
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $15,120 - $17,251
-252 Reduced 40.51%
370 $23,000
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $226 - $258
4 Added 0.65%
622 $36,000
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $186 - $234
3 Added 0.49%
618 $39,000
Q2 2020

Aug 12, 2020

SELL
$72.34 - $84.0 $121,820 - $141,456
-1,684 Reduced 73.25%
615 $42,000
Q1 2020

May 12, 2020

BUY
$62.63 - $80.22 $103,464 - $132,523
1,652 Added 255.33%
2,299 $171,000
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $39,868 - $43,853
647 New
647 $42,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ranch Capital Advisors Inc. Portfolio

Follow Ranch Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ranch Capital Advisors Inc. with notifications on news.